Morphine modulates cathepsin B and L activity in isolated glomeruli and mesangial cells

Related Experiment Videos

P C Singhal1, S Sagar, N Gibbons

  • 1Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, New York 10042.

Inflammation
|February 1, 1995
PubMed

Insights

Morphine, a heroin metabolite, boosts cathepsin B and L activity in kidney mesangial cells and glomeruli. This suggests a mechanism for heroin-induced kidney damage through enhanced matrix degradation.

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Altered matrix degradation is implicated in glomerulosclerosis development in heroin users.
  • Heroin abuse can lead to kidney damage, including mesangial expansion and glomerulosclerosis.

Purpose of the Study:

  • To investigate the effect of morphine, a primary heroin metabolite, on lysosomal cathepsin B and L activity.
  • To determine if morphine influences matrix-degrading enzymes in kidney mesangial cells and glomeruli.

Main Methods:

  • Cultured human mesangial cells were treated with morphine (10^-6 M).
  • Lysosomal cathepsin B and L activity was measured in mesangial cells and isolated glomeruli.
  • Dose-dependent effects of morphine were assessed.

Main Results:

  • Morphine significantly increased cathepsin B and L activity in mesangial cells (P < 0.01).
  • Morphine also significantly elevated cathepsin B and L activity in isolated glomeruli (P < 0.01).
  • The observed increase in enzyme activity was dose-dependent.

Conclusions:

  • Morphine enhances cathepsin B and L activity in kidney mesangial cells and glomeruli.
  • This morphine-induced increase in enzyme activity may contribute to enhanced mesangial cell capacity for matrix degradation.
  • These findings suggest a potential mechanism linking heroin use to kidney pathology via matrix remodeling.

Related Concept Videos